On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%. In particular, fees for doctors’ examinations were increased by 35%, case-based packages were increased by 45%, fees for other procedures were increased by 40%, fees for dialysis were increased by 50%, and fees for medical devices were increased by 75%.
In addition, the categories of reimbursement codes for cytogenetic and molecular tests have been reorganized. Instead of old chapters for cytogenetic and molecular tests, the following chapters now exist (these chapters can be found in Annexes 2B and 2A-2 of the SUT):
- 9.B. Cytogenetic tests (seven tests);
- 9.B.1. Molecular cytogenetic tests (24 tests);
- 9.C. Molecular genetic tests (149 tests);
- 9.C.1. Oncologic molecular tests (16 tests).
The full details in Turkish can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.